Moreover, high SRCIN1 mRNA expression was found in secondary event-free survival (321 patients) while a low expression was significantly associated with reduced secondary event-free survival (177 patients) leading to the conclusion that SRCIN1 is a prognostic risk factor for NB. Here, SRCIN1 is linked to neuroblastoma.